IL6 and cancer: In addition, variants in the TNFA gene (-308 G/A) and IL6 have been identified in various cancers, such as melanoma and other solid tumors, that increase the production of pro-inflammatory cytokines, which may predict the increased severity of CRS [20,21,22,23,24,25].